„13th ISABS Conference on Applied Genetics and Mayo Clinic Lectures in Translational Medicine “ confirmed speakers:
Nobel Laureate Lectures:
Aaron Ciechanover (Nobel Prize in Chemistry 2004; Technion – Israel Institute of Technology, Haifa, Israel): Bioethics and COVID-19; it is not only the virus, the disease and the vaccine
Svante Pääbo (Nobel Prize in Physiology and Medicine 2022; Max Planck Institute for Evolutionary Anthropology in Leipzig, Germany): Archaic genomics
Richard Roberts (Nobel Prize in Physiology and Medicine 1993; Northeastern University, Boston, MA, USA & New England Biolabs, Ipswich, MA, USA): The many roles of DNA methylation in bacteria
Gregg Semenza (Nobel Prize in Physiology and Medicine 2019; Johns Hopkins School of Medicine, Baltimore, MD, USA): Role of Hypoxia-Inducible Factors in Oxygen Homeostasis and Cancer Progression
Conference Distinguished Lecture:
Manfred Kayser (Erasmus University Medical Center Rotterdam, Rotterdam, Netherlands): Genetic research to improve forensic practice: the last 20 years
ISABS Lecture:
John Ioannidis (Stanford University, Stanford, CA, USA): Science, scientists, and scientific publications: the quest for reproducible and useful research
Moses Samuel Schanfield Memorial Session on Forensic Genetics
Frederick Bieber (Harvard University, Cambridge, MA, USA): A close view of forensic genetic genealogy: Successes, challenges and misapplications of genealogists
Bruce Budowle (Department of Forensic Medicine, University of Helsinki, Helsinki, Finland, and Forensic Science Institute, Radford University, Radford, VA, USA): Enhancing human identification with a well-structured forensic investigative genetic genealogy program
Mitchell Holland (Pennsylvania State University, State College, PA, USA): Analysis of HiFi mitogenome sequence data from the PaqBio Seuqel IIe
Walther Parson (Medical University of Innsbruck, Austria): From forensic genetics to forensic genomics: the mtDNA perspective
Antti Sajantila (University of Helsinki, Helsinki, Finland): Bridging forensic virology and archaeovirology
Susan Walsh (Perdue School of Science, Indianapolis, IN, USA): From a skull to a face using Forensic DNA phenotyping
Henry Lee (College of Criminal Justice and Forensic Sciences, University of New Haven, West Haven, CT, USA; Henry C. Lee Institute, West Haven, CT, USA): Use and Abuse of Genetics Evidence in Court
Mayo Clinic Lectures in Translational Medicine Program:
Zvia Agur (Institute for Medical BioMathematics, Tel Aviv, Israel): Why do COVID-19 patients die?
Julie G. Allickson (Mayo Clinic College of Medicine and Science and Mayo Clinic Center for Regenerative Biotherapeutics, Rochester, MN, USA): How we streamline operations for commercial success with execution of early phase clinical trials
Atta Behfar ((Mayo Clinic, Rochester, MN, USA): Acellular approach for cardiovascular regeneration and wound healing
Zwi Berneman (University of Antwerp, Antwerp, Belgium): Dendritic cell vaccination in cancer and auto-immune disease
Kapil Bharti (National Institutes of Health, Bethesda, MD, USA): Developing an autologous iPS cell-based therapy for age-related macular degeneration
Jung Kyoon Choi (Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Korea): Immunogenomic AI for cancer immunotherapy and diagnosis
Henry Erlich (Children's Hospital Oakland Research Institute, Oakland, CA, USA): In silico sequence, size selection and haplotyping using Oxford Nanopore applied to non-invasive prenatal testing of hemoglobinopathies
Christopher Evans (Mayo Clinic, Rochester, MN, USA): Progress in clinical translation of gene therapy for osteoarthritis.
Robert Ferris (University of Pittsburgh Medical Center, Pittsburgh, PA, USA): Developing innovative therapies and matching treatment intensity for head and neck cancer patients
Arezou A. Ghazani (Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA): Advancing precision medicine through integration of large-scale genome and clinical data
Massimiliano Gnecchi (University of Pavia, Pavia, Italy): Induced pluripotent stem cells for personalized risk stratification and therapy in patients with cardiac disease; Mesenchymal stromal cell secretome for heart repair
Mateja Hajdinjak (Max Planck Institute for Evolutionary Anthropology, Leipzig, Germany): Zooming in into late Neandertal populations
Robert Hariri (Weill Medical College, Cornell University, New York, NY; Celularity, Florian Park, NJ, USA) ): Stem cell therapies for human health and aging
Tae Hyun Hwang (Mayo Clinic, Jacksonville, FL, USA): AI-driven 3D modeling and analysis of tumor immune microenvironment and live cell imaging
Manolis Kellis (Massachusetts Institute of Technology, The Broad Institute, Cambridge, MA, USA): AI for genomic medicine and therapeutic development
Saad Kenderian (Mayo Clinic College of Medicine and Science, Rochester, MN, USA): Chimeric antigen receptor T cell therapy: where are we now and in 2030
Toomas Kivisild (Catholic University Leuven, Leuven, Belgium): Formation of local population structure in North Europe during and after plague pandemics
Guido Kroemer (Université de Paris, Sorbonne Université, Institut Gustave Roussy, Hôpital Européen Georges Pompidou): Stress hormones interfering with cancer immunosurveillance
Gordan Lauc (Max Planck Institute for Evolutionary Anthropology, Leipzig, Germany, University of Zagreb and Genos, Ltd., Zagreb, Croatia): Glycan biomarkers for personalized preventive healthcare
Nathan LeBrasseur (Mayo Clinic College of Medicine and Science, Rochester, MN, USA): Targeting cellular senescence for healthy aging
David Lott (Mayo Clinic College of Medicine and Science, Phoenix, AZ, USA): Translational tissue engineering
Jorge Mallea (Mayo Clinic College of Medicine and Science, Jacksonville, FL, USA): Machine perfusion: A platform for organ repair and regeneration
Shai Meretzki (Bonus BioGroup, Haifa, Israel): Advancing the future of regenerative medicine: Cells and tissue priming for successful translation of effective and accessible therapies
Eskeatnaf Mulugeta (Erasmus University Medical Center Rotterdam, Rotterdam, Netherlands): The Future of Crime Investigation in the era of Single-Cell Omics
Giuseppe Orlando (Wake Forest University School of Medicine): Regenerative Medicine Applications to Transplant Medicine with an Emphasis on Mitochondrial Transplantation
Dragan Primorac (ISABS & St. Catherine Specialty Hospital, Zagreb, Croatia; Universities of Split, Osijek and Rijeka, Croatia; Eberly College of Science, The Pennsylvania State University, University Park, State College, PA, USA; The Henry C. Lee College of Criminal Justice and Forensic Sciences, University of New Haven, West Haven, CT, USA; Regiomed Kliniken, Coburg, Germany): Understanding molecular effect of micro-fragmented adipose tissue (MFAT) and mesenchymal stromal cell (MSC) therapy of osteoarthritis
Elisabeth Rosado Balmayor (MERLN Institute, Maastricht, The Netherlands): Messenger RNA to induce tissue healing
Thomas Salinas (Mayo Clinic, Rochester, MN, USA): Updates in oral/systemic health and reconstruction of craniofacial defects
Ron van Schaik (Erasmus University, Rotterdam, Netherlands): Pharmacogenetics: do YOU have your DNA passport for medication?
Nidhi Shah (Dartmouth Hitchcock Medical Center, Lebanon, NH, USA): Genomic Frontiers: Towards Universal Newborn Sequencing
Nikolaos Skartsis (Mayo Clinic College of Medicine and Science, Rochester, MN, USA): Inflammation-trained Tregs for Cell Therapy
Doris Taylor (Organmet Bio, Inc., Houston, TX, USA): Biomanufacturing Regenerative Medicine Solutions for Heart Disease in 2024: From Genes to Organs
Serena Tucci (Yale University, New Haven, CT, USA): The genomic legacy of archaic hominin introgression
Samuel Volchenboum (The University of Chicago Medicine, Chicago, IL, USA): Data for the common good: Transforming health through data
Peter Wehling (Duke University, NC, USA and Dr. Wehling & Partner, Düsseldorf, Germany): Secretome-based therapy in chronic pain/OA patients and sports Injury - Biology, clinical results and cases
Laurence Zitvogel (Institut Gustave Roussy, Villejuif, France): The dirty secret of cancer immunotherapy
